Columbia University, New York, NY, USA.
Columbia University, New York, NY, USA.
Lancet Respir Med. 2020 Jan;8(1):34-44. doi: 10.1016/S2213-2600(19)30276-0. Epub 2019 Oct 9.
Former smokers now outnumber current smokers in many developed countries, and current smokers are smoking fewer cigarettes per day. Some data suggest that lung function decline normalises with smoking cessation; however, mechanistic studies suggest that lung function decline could continue. We hypothesised that former smokers and low-intensity current smokers have accelerated lung function decline compared with never-smokers, including among those without prevalent lung disease.
We used data on six US population-based cohorts included in the NHLBI Pooled Cohort Study. We restricted the sample to participants with valid spirometry at two or more exams. Two cohorts recruited younger adults (≥17 years), two recruited middle-aged and older adults (≥45 years), and two recruited only elderly adults (≥65 years) with examinations done between 1983 and 2014. FEV decline in sustained former smokers and current smokers was compared to that of never-smokers by use of mixed models adjusted for sociodemographic and anthropometric factors. Differential FEV decline was also evaluated according to duration of smoking cessation and cumulative (number of pack-years) and current (number of cigarettes per day) cigarette consumption.
25 352 participants (ages 17-93 years) completed 70 228 valid spirometry exams. Over a median follow-up of 7 years (IQR 3-20), FEV decline at the median age (57 years) was 31·01 mL per year (95% CI 30·66-31·37) in sustained never-smokers, 34·97 mL per year (34·36-35·57) in former smokers, and 39·92 mL per year (38·92-40·92) in current smokers. With adjustment, former smokers showed an accelerated FEV decline of 1·82 mL per year (95% CI 1·24-2·40) compared to never-smokers, which was approximately 20% of the effect estimate for current smokers (9·21 mL per year; 95% CI 8·35-10·08). Compared to never-smokers, accelerated FEV decline was observed in former smokers for decades after smoking cessation and in current smokers with low cumulative cigarette consumption (<10 pack-years). With respect to current cigarette consumption, the effect estimate for FEV decline in current smokers consuming less than five cigarettes per day (7·65 mL per year; 95% CI 6·21-9·09) was 68% of that in current smokers consuming 30 or more cigarettes per day (11·24 mL per year; 9·86-12·62), and around five times greater than in former smokers (1·57 mL per year; 1·00-2·14). Among participants without prevalent lung disease, associations were attenuated but were consistent with the main results.
Former smokers and low-intensity current smokers have accelerated lung function decline compared with never-smokers. These results suggest that all levels of smoking exposure are likely to be associated with lasting and progressive lung damage.
National Institutes of Health, National Heart Lung and Blood Institute, and US Environmental Protection Agency.
在许多发达国家,现在的戒烟者人数超过了当前吸烟者,而当前吸烟者每天吸烟的数量也在减少。一些数据表明,戒烟后肺功能下降会趋于正常;然而,机制研究表明,肺功能下降可能会持续。我们假设,与从不吸烟者相比,戒烟者和低强度的当前吸烟者的肺功能下降速度更快,包括那些没有常见肺部疾病的人。
我们使用了包含在 NHLBI 合并队列研究中的六个美国基于人群的队列的数据。我们将样本限制在两次或更多次检查中具有有效肺活量测定结果的参与者。两个队列招募了年轻成年人(≥17 岁),两个招募了中年和老年成年人(≥45 岁),两个仅招募了老年成年人(≥65 岁),检查时间为 1983 年至 2014 年。使用混合模型调整社会人口统计学和人体测量因素,比较持续戒烟者和当前吸烟者的 FEV 下降与从不吸烟者的 FEV 下降。还根据戒烟持续时间、累积(吸烟包年数)和当前(每天吸烟支数)吸烟量评估了 FEV 的差异下降。
25352 名参与者(年龄 17-93 岁)完成了 70228 次有效的肺活量检查。在中位数为 7 年(IQR 3-20)的中位随访期间,在中位年龄(57 岁)时,持续从不吸烟者的 FEV 下降率为 31.01mL/年(95%CI 30.66-31.37),戒烟者为 34.97mL/年(34.36-35.57),当前吸烟者为 39.92mL/年(38.92-40.92)。调整后,与从不吸烟者相比,戒烟者的 FEV 下降速度加快了 1.82mL/年(95%CI 1.24-2.40),这大约是当前吸烟者的 20%(9.21mL/年;95%CI 8.35-10.08)。与从不吸烟者相比,戒烟者在戒烟后数十年内以及在累积吸烟量较低(<10 包年)的当前吸烟者中,肺功能下降速度加快。关于当前的吸烟量,每天吸烟少于五支(7.65mL/年;95%CI 6.21-9.09)的当前吸烟者的 FEV 下降估计值是每天吸烟 30 支或更多的当前吸烟者的 68%(11.24mL/年;9.86-12.62),是戒烟者的 5 倍左右(1.57mL/年;1.00-2.14)。在没有常见肺部疾病的参与者中,相关性减弱,但与主要结果一致。
与从不吸烟者相比,戒烟者和低强度的当前吸烟者的肺功能下降速度更快。这些结果表明,所有水平的吸烟暴露都可能与持续和进行性的肺部损伤有关。
美国国立卫生研究院、美国国家心肺血液研究所和美国环境保护署。